Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Vascular Delivery of Allogeneic MuStem Cells in Dystrophic Dogs Requires Only Short-Term Immunosuppression to Avoid Host Immunity and Generate Clinical/Tissue Benefits.

Lorant J, Larcher T, Jaulin N, Hedan B, Lardenois A, Leroux I, Dubreil L, Ledevin M, Goubin H, Moullec S, Deschamps JY, Thorin C, André C, Adjali O, Rouger K.

Cell Transplant. 2018 Jul;27(7):1096-1110. doi: 10.1177/0963689718776306. Epub 2018 Jun 5.

2.

Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation.

Robriquet F, Babarit C, Larcher T, Dubreil L, Ledevin M, Goubin H, Rouger K, Guével L.

BMC Musculoskelet Disord. 2016 May 11;17:209. doi: 10.1186/s12891-016-1060-5.

3.

Differential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell Transplantation.

Robriquet F, Lardenois A, Babarit C, Larcher T, Dubreil L, Leroux I, Zuber C, Ledevin M, Deschamps JY, Fromes Y, Cherel Y, Guevel L, Rouger K.

PLoS One. 2015 May 8;10(5):e0123336. doi: 10.1371/journal.pone.0123336. eCollection 2015.

4.

Quantitative proteome profiling of dystrophic dog skeletal muscle reveals a stabilized muscular architecture and protection against oxidative stress after systemic delivery of MuStem cells.

Lardenois A, Jagot S, Lagarrigue M, Guével B, Ledevin M, Larcher T, Dubreil L, Pineau C, Rouger K, Guével L.

Proteomics. 2016 Jul;16(14):2028-42. doi: 10.1002/pmic.201600002.

5.

Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin.

Vieira NM, Valadares M, Zucconi E, Secco M, Bueno CR Jr, Brandalise V, Assoni A, Gomes J, Landini V, Andrade T, Caetano HV, Vainzof M, Zatz M.

Cell Transplant. 2012;21(7):1407-17. doi: 10.3727/096368911X.

PMID:
23168016
6.

Early transplantation of human immature dental pulp stem cells from baby teeth to golden retriever muscular dystrophy (GRMD) dogs: Local or systemic?

Kerkis I, Ambrosio CE, Kerkis A, Martins DS, Zucconi E, Fonseca SA, Cabral RM, Maranduba CM, Gaiad TP, Morini AC, Vieira NM, Brolio MP, Sant'Anna OA, Miglino MA, Zatz M.

J Transl Med. 2008 Jul 3;6:35. doi: 10.1186/1479-5876-6-35.

7.

Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.

Vieira NM, Spinazzola JM, Alexander MS, Moreira YB, Kawahara G, Gibbs DE, Mead LC, Verjovski-Almeida S, Zatz M, Kunkel LM.

Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):6080-6085. doi: 10.1073/pnas.1703556114. Epub 2017 May 22.

8.

The golden retriever model of Duchenne muscular dystrophy.

Kornegay JN.

Skelet Muscle. 2017 May 19;7(1):9. doi: 10.1186/s13395-017-0124-z. Review.

9.

Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs.

Rouger K, Larcher T, Dubreil L, Deschamps JY, Le Guiner C, Jouvion G, Delorme B, Lieubeau B, Carlus M, Fornasari B, Theret M, Orlando P, Ledevin M, Zuber C, Leroux I, Deleau S, Guigand L, Testault I, Le Rumeur E, Fiszman M, Chérel Y.

Am J Pathol. 2011 Nov;179(5):2501-18. doi: 10.1016/j.ajpath.2011.07.022. Epub 2011 Sep 13.

10.

Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures.

Kornegay JN, Bogan DJ, Bogan JR, Dow JL, Wang J, Fan Z, Liu N, Warsing LC, Grange RW, Ahn M, Balog-Alvarez CJ, Cotten SW, Willis MS, Brinkmeyer-Langford C, Zhu H, Palandra J, Morris CA, Styner MA, Wagner KR.

Skelet Muscle. 2016 Apr 4;6:14. doi: 10.1186/s13395-016-0085-7. eCollection 2016.

11.

Glucose Metabolism as a Pre-clinical Biomarker for the Golden Retriever Model of Duchenne Muscular Dystrophy.

Schneider SM, Sridhar V, Bettis AK, Heath-Barnett H, Balog-Alvarez CJ, Guo LJ, Johnson R, Jaques S, Vitha S, Glowcwski AC, Kornegay JN, Nghiem PP.

Mol Imaging Biol. 2018 Oct;20(5):780-788. doi: 10.1007/s11307-018-1174-2.

12.

Muscle lesions associated with dystrophin deficiency in neonatal golden retriever puppies.

Nguyen F, Cherel Y, Guigand L, Goubault-Leroux I, Wyers M.

J Comp Pathol. 2002 Feb-Apr;126(2-3):100-8.

PMID:
11944998
13.

Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy.

Terrill JR, Duong MN, Turner R, Le Guiner C, Boyatzis A, Kettle AJ, Grounds MD, Arthur PG.

Redox Biol. 2016 Oct;9:276-286. doi: 10.1016/j.redox.2016.08.016. Epub 2016 Aug 30.

14.

NBD delivery improves the disease phenotype of the golden retriever model of Duchenne muscular dystrophy.

Kornegay JN, Peterson JM, Bogan DJ, Kline W, Bogan JR, Dow JL, Fan Z, Wang J, Ahn M, Zhu H, Styner M, Guttridge DC.

Skelet Muscle. 2014 Oct 23;4:18. doi: 10.1186/2044-5040-4-18. eCollection 2014.

15.

Anatomical and mesoscopic characterization of the dystrophic diaphragm: An in vivo nuclear magnetic resonance imaging study in the Golden retriever muscular dystrophy dog.

Thibaud JL, Matot B, Barthélémy I, Fromes Y, Blot S, Carlier PG.

Neuromuscul Disord. 2017 Apr;27(4):315-325. doi: 10.1016/j.nmd.2017.02.003. Epub 2017 Feb 7.

PMID:
28258941
16.

Alteration of cardiac progenitor cell potency in GRMD dogs.

Cassano M, Berardi E, Crippa S, Toelen J, Barthelemy I, Micheletti R, Chuah M, Vandendriessche T, Debyser Z, Blot S, Sampaolesi M.

Cell Transplant. 2012;21(9):1945-67. doi: 10.3727/096368912X638919. Epub 2012 Apr 10.

17.

Genome-wide association study to identify potential genetic modifiers in a canine model for Duchenne muscular dystrophy.

Brinkmeyer-Langford C, Balog-Alvarez C, Cai JJ, Davis BW, Kornegay JN.

BMC Genomics. 2016 Aug 22;17:665. doi: 10.1186/s12864-016-2948-z.

18.

Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy.

Barthélémy I, Pinto-Mariz F, Yada E, Desquilbet L, Savino W, Silva-Barbosa SD, Faussat AM, Mouly V, Voit T, Blot S, Butler-Browne G.

Dis Model Mech. 2014 Nov;7(11):1253-61. doi: 10.1242/dmm.016014. Epub 2014 Sep 26.

19.

High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with immunosuppression.

Howell JM, Lochmüller H, O'Hara A, Fletcher S, Kakulas BA, Massie B, Nalbantoglu J, Karpati G.

Hum Gene Ther. 1998 Mar 20;9(5):629-34.

PMID:
9551611
20.

Skeletal Muscle Regenerative Potential of Human MuStem Cells following Transplantation into Injured Mice Muscle.

Lorant J, Saury C, Schleder C, Robriquet F, Lieubeau B, Négroni E, Leroux I, Chabrand L, Viau S, Babarit C, Ledevin M, Dubreil L, Hamel A, Magot A, Thorin C, Guevel L, Delorme B, Péréon Y, Butler-Browne G, Mouly V, Rouger K.

Mol Ther. 2018 Feb 7;26(2):618-633. doi: 10.1016/j.ymthe.2017.10.013. Epub 2017 Oct 20.

Supplemental Content

Support Center